Physician

Scott G. Foxman, MD

According to 2025 Medicare claims, Scott Foxman, MD (NPI: 1447224175) practices ophthalmology in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is RETINAL & OPHTHALMIC CONSULTANTS, P.C. (NPI: 1750356481; TIN: 223146260) and primary practice location at 08225-1827.

Foxman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 504 traditional Medicare patients, billed 37,400 HCPCS/CPT codes, and received $2,222,623 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 192 prescription claims across 47 beneficiaries totaling $10,287 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $50. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $4,642,374 to $2,222,623. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $12,325 and ending at $10,287. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.4M$4.8M2015 Medicare payment: $4,642,374 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,826,289 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,437,617 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,142,647 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,527,018 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,775,562 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,645,847 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,256,721 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,103,225 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,222,623 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,31416,024$4,642,374
20161,15916,862$4,826,289
20171,04915,137$4,437,617
201896413,897$4,142,647
201978911,445$3,527,018
20206909,870$2,775,562
20216709,140$2,645,847
202257110,736$2,256,721
202351528,555$2,103,225
202450437,400$2,222,623

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.3K$19K2015 Drug cost: $12,325 (USD; Tot_Drug_Cst)2016 Drug cost: $13,269 (USD; Tot_Drug_Cst)2017 Drug cost: $18,084 (USD; Tot_Drug_Cst)2018 Drug cost: $14,280 (USD; Tot_Drug_Cst)2019 Drug cost: $18,632 (USD; Tot_Drug_Cst)2020 Drug cost: $14,546 (USD; Tot_Drug_Cst)2021 Drug cost: $13,967 (USD; Tot_Drug_Cst)2022 Drug cost: $9,930 (USD; Tot_Drug_Cst)2023 Drug cost: $12,811 (USD; Tot_Drug_Cst)2024 Drug cost: $10,287 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201565167$12,325
201668181$13,269
201780221$18,084
201863172$14,280
201962172$18,632
202062183$14,546
202148187$13,967
202243160$9,930
202346198$12,811
202447192$10,287

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2141,013$108
92014Established patient complete exam of visual system279361$101
92012Established patient problem focused exam of visual system213550$72
92134Imaging of retina4791,181$33
J2777Injection, faricimab-svoa, 0.1 mg12128,020$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate341,389$2,007
TravoprostTravoprost17555$1,468
Ketorolac TromethamineKetorolac Tromethamine17809$395
LatanoprostLatanoprost17910$281
Timolol MaleateTimolol Maleate14800$185

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$50Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Scott G. Foxman, MD?

Tedicare shows public-source Medicare data for Scott G. Foxman, MD (NPI 1447224175), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott G. Foxman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott G. Foxman, MD?

Scott G. Foxman, MD is linked to RETINAL & OPHTHALMIC CONSULTANTS, P.C. (billing NPI 1750356481) in the available physician profile data.

Does Scott G. Foxman, MD have Open Payments data?

Scott G. Foxman, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.